681TiP A phase I/II, open label, multi-center, non-randomized dose escalation and dose expansion study of AMXI-5001 in patients with advanced malignancies.

Saved in:
Bibliographic Details
Title: 681TiP A phase I/II, open label, multi-center, non-randomized dose escalation and dose expansion study of AMXI-5001 in patients with advanced malignancies.
Authors: Rosen, L.S.1 (AUTHOR), Azad, N.2 (AUTHOR), Costa, R.3 (AUTHOR), Meric-Bernstam, F.4 (AUTHOR), Alaoui, H.5 (AUTHOR), Jablons, D.M.6 (AUTHOR), Munster, P.7 (AUTHOR), Hamilton, E.P.8 (AUTHOR)
Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS531-S531. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2024.08.747